Medtronic (MDT)
89.53
+0.00 (0.00%)
NYSE · Last Trade: Jul 18th, 7:23 AM EDT
Detailed Quote
Previous Close | 89.53 |
---|---|
Open | - |
Bid | 88.34 |
Ask | 89.88 |
Day's Range | N/A - N/A |
52 Week Range | 77.94 - 96.25 |
Volume | 218 |
Market Cap | 120.32B |
PE Ratio (TTM) | 24.73 |
EPS (TTM) | 3.6 |
Dividend & Yield | 2.800 (3.13%) |
1 Month Average Volume | 8,256,032 |
Chart
About Medtronic (MDT)
Medtronic is a global leader in medical technology, focused on developing and providing innovative therapeutic solutions to improve the lives of patients. The company specializes in a wide range of medical devices and therapies, addressing conditions in areas such as diabetes care, cardiovascular health, surgical innovations, and neurological disorders. Medtronic is committed to advancing healthcare through cutting-edge research, collaboration with healthcare providers, and a strong emphasis on patient-centered care, aiming to enhance the quality of life for millions around the world. Read More
News & Press Releases
The company's second biggest product missed sales expectations. Shares look likely to undercut a buy zone.
Via Investor's Business Daily · July 17, 2025
The company issued a light outlook for 2025 organic sales growth despite beating second-quarter forecasts.
Via Investor's Business Daily · July 17, 2025
MEDTRONIC PLC (NYSE:MDT) appears undervalued with strong profitability, a solid dividend, and stable financials, making it a candidate for value investors.
Via Chartmill · July 17, 2025
The company is also restructuring with the hopes of saving $400 million in expenses.
Via Investor's Business Daily · July 16, 2025
Australia, July 16, 2025 -- Not Just a Patch, a developer of medical CGM covers and patches solutions, has received U.S. Food and Drug Administration (FDA) clearance and European Class 1 medical device certification for its line of waterproof adhesive patches designed for continuous glucose monitoring (CGM) devices. These regulatory milestones will allow the company to expand its distribution footprint across North America and Europe, reinforcing market confidence in its CGM support products.
Via Press Release Distribution Service · July 16, 2025
CMS’s Initial Proposal To Cover Renal Denervation A Win For Medtronic, Says Analystsstocktwits.com
Via Stocktwits · July 11, 2025
Via Benzinga · July 16, 2025
MEDTRONIC PLC (NYSE:MDT) offers a solid 3.18% dividend yield, strong profitability, and reasonable valuation, making it a candidate for dividend investors. The company has a reliable payout history and decent financial health.
Via Chartmill · July 15, 2025
Robotics adoption is accelerating globally, with AI, automation, and real-time data processing reshaping industries from healthcare to manufacturing.
Via MarketBeat · July 14, 2025
Bank of America names its highest-conviction stock ideas for Q3 2025—8 Buys and 2 Underperforms. Boeing, Cisco, and Datadog top the list.
Via Benzinga · July 12, 2025
CMS proposed Medicare coverage for Medtronic's renal denervation therapy for high blood pressure, signaling a key step toward broader adoption.
Via Benzinga · July 11, 2025
Via The Motley Fool · July 11, 2025
A steady dose of quality companies will keep your portfolio growing big and strong.
Via The Motley Fool · July 11, 2025
Chad Spooner’s appointment will be effective July 14, and he will be responsible for overseeing the Finance function for Medtronic Diabetes and supporting initiatives.
Via Stocktwits · July 8, 2025
Merit Medical appoints Medtronic veteran Martha Aronson as CEO, projecting strong Q2 revenue above estimates.
Via Benzinga · July 8, 2025
The company expects second-quarter revenue to grow by as much as 14% year-over-year, with foreign exchange headwinds expected to trim approximately $2.3 million from the top line.
Via Stocktwits · July 7, 2025
DETROIT, MI - July 7, 2025 - Bond, a Detroit-based consumer wearable technology company, today announced the official launch of the Bond Ring™, positioning itself as the most advanced wearable wellness device in the smart ring market. The groundbreaking technologies integrates 11 breakthrough capabilities while being powered by the company's patent-pending LifeDrive technology, marking a significant advancement in wearable health monitoring.
Via Get News · July 7, 2025
A proposal would cut Medicare reimbursements for some medical devices using a competitive bidding process.
Via Investor's Business Daily · July 1, 2025
These 3 dividend stocks offer strong balance sheets, low debt, and reliable payouts, making them solid long-term picks for income investors
Via MarketBeat · July 1, 2025
Via Benzinga · June 30, 2025
Forever is a tricky word in the stock market, but these stocks are as safe as they come and will pay you to hold them.
Via The Motley Fool · June 26, 2025
San Francisco, California, United States, June 25, 2025 -- G3 Partners, a boutique investment attraction agency, is pleased to announce a strategic alliance with Procomer, Costa Rica’s Foreign Trade & Investment Promotion Agency. The new location will serve as a strategic gateway to deepen investment ties between Costa Rica and the western United States, particularly in key growth sectors such as semiconductors, medical devices, advanced manufacturing, corporate services and digital technology, agribusiness , and tourism infrastructure .
Via Press Release Distribution Service · June 25, 2025